MOONBAT Co.,Ltd.
MOONBAT Co.,Ltd. (8115.T) Financial Performance & Income Statement Overview
Explore the financials of MOONBAT Co.,Ltd. (8115.T), including yearly and quarterly data on income, cash flow, and balance sheets.
MOONBAT Co.,Ltd. (8115.T) Income Statement & Financial Overview
Review MOONBAT Co.,Ltd. 8115.T income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.67B | $2.60B | $2.81B | $3.86B |
| Cost of Revenue | $1.70B | $1.38B | $1.57B | $2.18B |
| Gross Profit | $978.32M | $1.22B | $1.25B | $1.68B |
| Gross Profit Ratio | $0.37 | $0.47 | $0.44 | $0.43 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.07B | $1.09B | $1.13B | $1.13B |
| Operating Expenses | $1.07B | $1.09B | $1.13B | $1.13B |
| Total Costs & Expenses | $2.76B | $2.47B | $2.70B | $3.31B |
| Interest Income | $1.03M | $0.00 | $580000.00 | $2.00M |
| Interest Expense | $6.001M | $0.00 | $4.86M | $0.00 |
| Depreciation & Amortization | $35.85M | $51.95M | $41.50M | $37.75M |
| EBITDA | -$796000.00 | $171.75M | $155.50M | $581.75M |
| EBITDA Ratio | -$0.00 | $0.07 | $0.06 | $0.15 |
| Operating Income | -$89.34M | $134.00M | $114.00M | $544.00M |
| Operating Income Ratio | -$0.03 | $0.05 | $0.04 | $0.14 |
| Other Income/Expenses (Net) | $46.69M | $19.00M | -$30.00M | -$25.00M |
| Income Before Tax | -$42.65M | $153.00M | $84.00M | $519.00M |
| Income Before Tax Ratio | -$0.02 | $0.06 | $0.03 | $0.13 |
| Income Tax Expense | -$8.85M | $38.00M | $4.00M | $94.00M |
| Net Income | -$35.45M | $114.00M | $79.00M | $425.00M |
| Net Income Ratio | -$0.01 | $0.04 | $0.03 | $0.11 |
| EPS | -$7.76 | $25.28 | $17.52 | $94.11 |
| Diluted EPS | -$7.76 | $25.28 | $17.52 | $94.11 |
| Weighted Avg Shares Outstanding | $4.51M | $4.51M | $4.51M | $4.52M |
| Weighted Avg Shares Outstanding (Diluted) | $4.51M | $4.51M | $4.51M | $4.52M |
Over the last four quarters, MOONBAT Co.,Ltd. achieved steady financial progress, growing revenue from $3.86B in Q1 2024 to $2.67B in Q4 2024. Gross profit stayed firm with margins at 37% in Q4 2024 versus 43% in Q1 2024. Operating income totaled -$89.34M in Q4 2024, maintaining a -3% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$796000.00. Net income dropped to -$35.45M, with EPS at -$7.76. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan